BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

3 Months Ended

Mar. 31, 2018

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three months ended March 31, 2018 and 2017 are as follows:

	Three Months Ended
	March 31,
	2018							2017
Laser systems	$	5,703			57.0	%		$	6,729			61.9	%
Imaging systems		583			5.8	%			626			5.7	%
Consumables and other		2,034			20.3	%			1,692			15.6	%
Services		1,697			16.9	%			1,795			16.5	%
License fees and royalties		3			0.0	%			32			0.3	%
Total revenue	$	10,020			100.0	%		$	10,874			100.0	%